Qube Research & Technologies LTD Immuneering Corp Transaction History

Qube Research & Technologies LTD

  • $61.9 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$4.09 - $10.24 $24,863 - $62,248
6,079 Added 45.66%
19,394 $94,000
Q3 2022

Nov 14, 2022
SELL
$5.0 - $12.85 $13,135 - $33,756
-2,627 Reduced 16.48%
13,315 $191,000
Q2 2022

Aug 15, 2022
BUY
$3.89 - $7.81 $62,014 - $124,507
15,942 New
15,942 $86,000

Others Institutions Holding IMRX

# of Institutions
52
Shares Held
11.6M
Call Options Held
0
Put Options Held
0
View Full List

About Immuneering Corp

IMRX Quotes by TradingView
  • Ticker IMRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,392,300
  • Market Cap $33.8M
  • Description
  • Immuneering Corporation, a biopharmaceutical company, focuses on the oncology and neuroscience product candidates. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor to treat patients with cancer, including pancreatic, melanoma, colorectal, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 to tr...
More about IMRX
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email